The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,598,348 in first-year total cost, median $799,174.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-F (A1)]2
Most frequent institutions
- UNIVERSITY OF MINNESOTA1
- WEILL MEDICAL COLL OF CORNELL UNIV1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Intercepting progression from pre-invasive to invasive lung adenocarcinoma1UG3CA244697-01 | ALTORKI, NASSER KHALEDBORCZUK, ALAIN CELEMENTO, OLIVIERMCGRAW, TIMOTHY EMITTAL, VIVEK | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $836,730 | ZCA1 |
| 2019 | Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention1UG3CA244687-01 | LARGAESPADA, DAVID ANDREW | UNIVERSITY OF MINNESOTA, MN | $761,618 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.